METACARE CO., Ltd. (KRX:118000)
305.00
+3.00 (0.99%)
At close: Nov 26, 2025
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 52.39 billion as of November 26, 2025. Its market cap has decreased by -7.03% in one year.
Market Cap
52.39B
Enterprise Value
110.68B
Revenue
28.10B
Ranking
n/a
PE Ratio
42.49
Stock Price
305.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 52.39B, an increase of 31.58%. That is a compound annual growth rate of 1.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | 143.38B | 61.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Yuhan | 8.60T |
| Peptron | 7.30T |
| LigaChem Biosciences | 6.25T |